Baltimore Wins $80 Million Opioid Settlement with Walgreens
Tuesday, 10 September 2024, 12:04
Significant Opioid Settlement Achieved
Baltimore City has successfully negotiated an $80 million settlement with Walgreens, addressing allegations that the pharmacy chain contributed to the opioid crisis affecting many communities.
Background of the Settlement
- The recent financial recovery increases Baltimore's total from opioid settlements to $402.5 million.
- Earlier settlements include CVS and Allergan for $45 million, Cardinal Health for $152.5 million, and Teva for $80 million.
Upcoming Legal Challenges
Another significant case awaits as Baltimore prepares to bring Johnson & Johnson, McKesson, and AmerisourceBergen to trial next week, aiming for additional accountability in the fight against the opioid epidemic.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.